Tag: side-effects

The paradox of relieving chronic pain with an antidepressant (and a new set of symptoms).

Researchers report that dangerous side effects are not being adequately reported in the trials of ketamine for depression.

A large observational study published in CNS Drugs sheds light on serious adverse effects of the ‘gold standard’ antipsychotic Clozapine.

Data shows that over a third of users experience permanent memory loss and that approximately half report not receiving adequate information about the risks from their doctors.

An article published this month in the journal BMC Psychiatry suggests that there is a lack of efficacy for SSRIs and that they significantly increase the risk of serious side effects.

When the nurses tried to give him other medications, my father refused. They accused him of being “combative” and “uncooperative,” and they injected him with the highly toxic, incredibly dangerous, mind-bending antipsychotic HALDOL.

“It’s the biggest secret in medicine,” said F. Perry Wilson, a researcher and physician at Yale University School of Medicine. “For the vast majority of...

From MinnPost: “It’s Disney World versus the real world,” Dr. David Juurlink, a professor of medicine at the University of Toronto who studies drug safety,...

Researchers believe that side-effect monitoring is critical because of the increase in the use of antipsychotics

A new study finds that individuals being treated with open-label placebos showed significant reductions in pain and disability, even when compared to individuals receiving treatment as usual.

A new study finds that elderly individuals using antidepressants are at significantly higher risk for dementia compared to depressed individuals who did not take the drugs.

A group of researchers recently found serious bias in the reporting of harm due to adverse events in antidepressant medication clinical trials. They report...

The August issue of Psychotherapy and Psychosomatics published a review conducted by André F. Carvalho and colleagues regarding the literature around the long-term use...

The first systematic investigation of the adverse effects associated with prescribing drugs “off-label” found that the common practice of using drugs for conditions for which they are not approved increases the risk of adverse effects.

New York Times columnist, Nicholas Kristof, relates the story of Andrew Francesco, a boy who began taking Ritalin at age five and died from complications with Seroquel when he was fifteen. His father, a former pharmaceutical industry executive, reveals the industry’s greed in his memoir “Overmedicated and Undertreated.” Now the industry is pushing for a first-amendment right to market its drugs for off-label uses.

This week the drug monitoring and patients' rights website, RxISK, launched the Centre for Medication Withdrawal, a page dedicated to establishing what causes dependence and how to treat it.

Despite concerns about the drug’s necessity, effectiveness, and side-effects, Flibanserin (Addyi) has come to market as the first drug designed to increase sexual desire in women

Seeing others in pain may engage some of the same neural pathways as experiencing pain yourself, according to a new study covered by ScienceNow.

On his own website, clinical psychologist Kenneth Pope has summarized 60 meta-analyses of antidepressants published between 2013-2015. The studies contain information on antidepressants “uses,...

Antipsychotics are currently the predominant treatment for individuals diagnosed with schizophrenia, but there is an accumulating body of research that links the use of these drugs to structural abnormalities in the brain. A recent meta-analysis suggests that gray matter loss in the brain may depend on the dose and class of the antipsychotic.